8TH ANNUAL

INTERMOUNTAIN WEST HEPATOLOGY UPDATE

SATURDAY, MARCH 28, 2020

UN

IVER

SIT

Y O

F U

TAH

HE

ALT

HD

IVIS

ION

OF

GA

STR

OEN

TER

OLO

GY

30 N

orth

1900

Eas

t, 4R

118

Salt

Lake

City

, Uta

h 84

132

Non

-Pro

fitO

rgan

izat

ion

U.S.

Pos

tage

PAID

Salt

Lake

City

, UT

Perm

it #

1529

FORT DOUGLAS OFFICER’S CLUBSALT LAKE CITY

ScheduleStart End Speaker Title7:00 7:55 Breakfast and sign in

Moderator: Gallegos-Orozco7:55 8:00 Juan Gallegos-Orozco Welcome, Housekeeping, Introduction

8:00 8:30 Christian Ramers Hepatitis C Elimination: Miles to Go Before We Sleep

8:30 9:00 Kris Kowdley Fatty Liver—What to Do Now and What Will Change in the Next 5 Years

9:00 9:30 George Rodgers Coagulation in Cirrhosis—When to Intervene and What to Use

9:30 10:00 Ray Thomason Your Patient Has Elevated Ferritin—What Next?10:00 10:15 Panel Q&A10:15 10:30 Break

Moderator: Chandna10:30 11:00 Saira Khaderi What to Do About the Incidental Liver Mass

11:00 11:30 Catherine Frenette HCC: What to Do When Locoregional Therapy Isn’t Enough

11:30 12:00 Juan Gallegos-Orozco Is There Hope For the Patient With Cholangiocarcinoma?

12:00 12:15 Panel Q&A12:15 12:30 Ray Thomason Mid-Day Housekeeping Announcement12:30 1:00 Lunch

Moderator: Sussman1:00 1:30 Paul Pockros Do DAAs Increase the Risk of HCC?

1:30 2:00 Tuan Pham Challenges When Transplanting the Morbidly Obese Patient

2:00 2:30 Hugo Vargas Should We Transplant Patients with Acute Alcoholic Hepatitis?

2:30 3:00 Stephen Pappas Diagnosis and Management of Hepatorenal Syndrome Including the Role of Terlipressin

3:00 3:15 Panel Q&A3:15 3:30 Break

Moderator: Thomason

3:30 4:00 Shaun Chandna Recognizing and Treating Alpha-1 Antitrypsin Deficiency

4:00 4:30 Michael Schilsky Wilson Disease—Diagnosis, Initial Treatment, and Long-Term Follow Up

4:30 5:00 Norman Sussman The Role of Liver Transplantation in Wilson Disease

5:00 5:15 Panel Q&A5:15 5:30 Norman Sussman Wrap-Up5:30 5:35 Norman Sussman Closing Remarks and Next Year’s Date

5:35 Adjourn

EDUCATIONAL OBJECTIVES1. Review strategies to achieve hepatitis C elimination.2. Describe the current medical treatment of nonalcoholic fatty liver disease and recognize

therapies currently in development.3. Compare and contrast the role of liver transplant in patients with severe alcoholic hepatitis, in

patients with morbid obesity and in patients with Wilson disease.4. Review the diagnostic approach of the incidental liver mass.5. Understand the current treatment options for patients with hepatocellular carcinoma or

cholangiocarcinoma.6. Describe the diagnosis and management of hepatorenal syndrome, including the role of terlipressin.

LOCATIONThe course will be held at The Officer’s Club located at 150 South Fort Douglas Blvd., Building 649 Salt Lake City, Utah which is 18 miles south of the Salt Lake International Airport via a six-lane interstate highway (I-80).

TRANSPORTATIONSalt Lake City International Airport is served by 7 airlines with 645 daily flights. Airlines include, American, Delta, Frontier, Jet Blue, Southwest, United, and US Airways. Car rental facilities are located on the ground floor of the short-term parking garage directly across from the terminal buildings.UTA TRAX is available from the airport to downtown Salt Lake City.Public Transportation is available through UTA TRAX, Frontrunner, or bus. Visit www.rideuta.com for schedule and fares.

ACCOMMODATIONSFor your accommodations, you may book your room at the University Guest House which is less than a minute to walk to The Officer’s Club Conference Center where the conference will be held. The hotel offers a variety of accommodations, including hotel rooms and condominium style suites.For reservations, please call 1-888-416-4075. Be sure to reference the Intermountain West Hepatology Update Course 2020 in order to receive the conference rate. A very limited number of premier rooms are available at reduced cost; rooms need to be booked by Monday, January 22, 2020.Other choices range from boutique hotels such as Hotel Monaco and The Grand America to national names such as Marriott and Hyatt.Please obtain information at the reservation desk regarding deposit, cancellation, tax rate, village fee, service charges and available parking facility and fees.

CME STATEMENTAccreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.AMA Credit: The University of Utah School of Medicine designates this live activity for a maximum 9.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point’s equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, ethnicity, sex, disability, age, veteran’s status, religion, gender identity, gender expression, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

DIRECTORSJuan F. Gallegos-Orozco, MDNorman L. Sussman, MD, FAASLDRay Thomason, MD

FACULTYBaylor College of Medicine

Saira Khaderi, MDAssistant Professor of SurgeryHouston, TX

Stephen C. Pappas, MDAssociate Professor of MedicineHouston, TX

Norman Sussman, MDAssociate Professor of SurgeryHouston, TX

Family Health Centers of San Diego

Christian Ramers, MDAssistant Medical Director for Research & Special PopulationsSan Diego, CA

Mayo Clinic

Hugo Vargas, MDProfessor of MedicinePhoenix, AZ

Scripps Health

Catherine Frenette, MDMedical Director of Liver TransplantationLa Jolla, CA

Paul Pockros, MDProfessor of MedicineLa Jolla, CA

University of Utah

Shaun Chandna, MDAssistant Professor of MedicineSalt Lake City, UT

Juan Gallegos-Orozco, MDAssociate Professor of MedicineSalt Lake City, UT

Tuan Pham, MDAssistant Professor of MedicineSalt Lake City, UT

George Rodgers, MD, Ph.DProfessor of MedicineSalt Lake City, UT

Ray Thomason, MDAssistant Professor of MedicineSalt Lake City, UT

Washington State University

Kris Kowdley, MDClinical Professor of MedicineSpokane, WA

Yale School of Medicine

Michael Schilsky, MDProfessor of MedicineNew Haven, CT

We invite you to join us for a comprehensive overview of major advances in the field of liver diseases to be held on March 28, 2020 at the University of Utah’s Officer’s Club. Take advantage of this cutting edge educational program in the beautiful Wasatch Mountains.

COURSE DESCRIPTIONThis year the course will focus on the management of chronic liver diseases, including chronic hepatitis C, nonalcoholic fatty liver disease, Wilson disease and alpha 1 anti-trypsin deficiency. We will also discuss the role of liver transplant in patients with morbid obesity, severe alcoholic hepatitis and Wilson disease. Finally, this year we will also focus on the diagnostic approach of liver tumors with dedicated coverage of hepatocellular carcinoma and cholangiocarcinoma.

INTENDED AUDIENCEGastroenterologists, pharmacists, physician assistants, nurse practitioners, internists, family physicians and trainees.

8TH ANNUALINTERMOUNTAIN WEST HEPATOLOGY UPDATE 2020

www.imwconference.comUniversity of Utah Health, Baylor College of Medicine

REGISTRATIONOnline registration is now available!www.imwconference.comThe registration fee includes attendance at The Intermountain West Hepatology Update March 28, 2020.

If cancellation of your registration is necessary, you may send e-mail notice to Lynsey Bell at Lynsey.Bell@hsc.utah.edu. Cancellations made by January 31, 2020, will be accepted subject to a cancellation fee of $50. Confirmed registrants who do not attend the conference or who cancel after January 31, 2020, are responsible for the entire registration fee. Substitutions, however, may be made at any time.

If you have any questions you may contact Lynsey Bell by email at lynsey.bell@hsc.utah.edu, or by fax at 801-581-7476.

Register Online: www.imwconference.com.

Registration Form:Send your registration information via mail, fax or online. A confirmation letter will be sent upon receipt of the completed registration form.

Name Degree

Address

City State Zip

Tel ( ) - Fax ( ) -

E-Mail

Physician . . . . . . . . . $200 $

PA, NP . . . . . . . . . . . . $90 $

Residents and Fellows. . $90.00 $

Amount Enclosed $

Payment Method:I have enclosed a check made payable to:

Division of Gastroenterology, University of Utah HealthAttn: Lynsey BellDivision of GastroenterologyUniversity of Utah Health30 North 1900 East, 4R118 SOMSalt Lake City, Utah 84132-2406